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Edited by Ulf-Ingo Flu¨ggeAbstract Many mammalian ABC transporters move membrane
lipids to acceptor lipid assemblies in the extracellular aqueous
milieu. Because the desorption from the membrane costs more
energy than provided by two ATPs, the transporter probably
only translocates the lipid to a partially hydrophilic site on its
extracellular face. From this high-energy site, the lipid may eﬃ-
ciently move to the acceptor, which ideally is bound to the trans-
porter, or, in the absence of an acceptor, fall back into the
membrane. If the lipid originated from the cytosolic membrane
surface, this represents lipid ﬂop and is probably a side activity
of the transporters.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transbilayer movement1. ABC transporters and lipids
A relation between mammalian ABC transporters and lipid
transport was ﬁrst found by Smit and colleagues [1]. When
they knocked out the ABC transporter Mdr2 (Abcb4), a
close relative of the prototype multidrug transporter
MDR1 P-glycoprotein (ABCB1; [2]), they observed that the
mice were jaundiced and found out that this was due to a
lack of the phospholipid phosphatidylcholine (PC) in the
bile. Around the same time, the accumulation of very long-
chain fatty acids in adrenoleukodystrophy was linked to dele-
tions in ABCD1 [3]. Another milestone was the ﬁnding that
even a multidrug transporter like ABCB1 is able to transport
a wide variety of analogs of the regular membrane lipids
across the plasma membrane [4]. The subsequent decade
has witnessed the unmasking of many lipid-linked inherited
diseases as being caused by mutations in one of the ABC
transporters, and by now nearly half of the 49 or 50 human
ABC transporters is thought to be involved in lipid transport
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A phospholipid bilayer is the basic structure of all mem-
branes in mammalian cells. These membranes are not assem-
bled de novo. They are created by ﬁssion from an existing
membrane and, apart from mitochondria and peroxisomes,
the cellular membranes continuously exchange proteins and
lipids via the bidirectional traﬃc of membrane vesicles. Mam-
malian membranes have an oily consistency. Free diﬀusion of
membrane components would predict that the continuous mix-
ing would result in a uniform composition for all membranes.
This is clearly not the case: the various organelles display dif-
ferent protein and lipid compositions, whereby it must be
understood that they contain essentially the same lipids but
in diﬀerent ratios. The membranes of the late secretory path-
way and the endocytotic pathway are enriched in sphingolipids
and cholesterol, while in comparison the ER is highly enriched
in unsaturated glycerophospholipids. According to the prevail-
ing hypothesis, this is due to a spontaneous demixing of these
lipids in the plane of the membrane. Preferential interactions
with targeting proteins like SNARES must then ensure that
the diﬀerent lipid domains end up in separate transport carriers
that ship them to their speciﬁc destinations [7].
The unique protein and lipid composition of each membrane
endows them with unique physical properties. The membrane
of the ER is highly ﬂuid and, in addition, the phospholipid mol-
ecules rapidly equilibrate between the two leaﬂets of the lipid
bilayer with a half-time of seconds. This property is lost upon
the extraction and reconstitution of the ER lipids and for that
reason the quest for the bidirectional ER lipid ‘‘ﬂippase’’ is
ongoing [8]. The evidence predicts that this activity is energy-
independent. This is in contrast with, for example, the plasma
membrane which displays an asymmetric arrangement of the
various phospholipids, with an enrichment of the aminophosp-
holipids phosphatidylserine (PS) and phosphatidylethanol-
amine (PE) in the cytosolic and the choline-containing
phospholipids phosphatidylcholine (PC) and sphingomyelin
(SM) in the exoplasmic bilayer leaﬂet. PS is virtually exclusively
cytosolic and SM (and glycosphingolipids) exoplasmic. PE and
PC have less pronounced asymmetric distributions. As in
model membranes, the phospholipids do not freely move across
the plasma membrane bilayer. Apart from that, the asymmetri-
cal distribution is maintained by two mechanisms. First, SM
and most glycosphingolipids are synthesized on the exoplasmic,
lumenal aspect of the Golgi membrane, and, second, the
aminophospholipids are actively ‘‘ﬂipped’’ from exoplasmic
to cytosolic surfaces by members of a subfamily of P-typeblished by Elsevier B.V. All rights reserved.
Fig. 1. P-type ATPases. P-type ATPases of the P4 subfamily have been
suggested to ‘‘ﬂip’’ speciﬁc phospholipid classes: they translocate the
lipid from the exoplasmic leaﬂet (A) to the cytosolic leaﬂet of the
plasma membrane (B) while inverting its headgroup orientation.
Proteins of this family stimulate vesicle budding [10,11]. Probably, the
shift of lipid mass across the membrane increases the lateral pressure in
the cytosolic compared to the exoplasmic leaﬂet, which then relaxes by
curving the membrane inwards (C), and promotes endocytosis.
Fig. 2. (A) When a lipid desorbs from a membrane it goes through a
thermal activation state, in which the contacts of its lipidic portion
with the membrane have been broken [18,20]. The reversible partial
projection of molecules out of the bilayer may precede their collisional
capture by the acceptor [13]. (B) More likely, a transfer protein, or
another low molecular weight acceptor like cyclodextrin, upon contact
lowers the desorption activation energy by locally dehydrating the
membrane [87]. (C) Also, the close proximity of an acceptor membrane
(hydration repulsion starts at 25 A˚ [88]), lipoprotein or micelle lowers
the energy barrier during the collision (probably by ordering the water
layer) thereby facilitating desorption [20,89].
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each of the 15 human members remain to be determined, but
they are clearly important because a mutation in one of these
results in hereditary cholestasis. Moreover, by moving lipid
mass from one leaﬂet into the other they are thought to create
a mass imbalance that may be one of the driving forces for the
membrane bending (Fig. 1; [9]). In yeast, they play important
roles in vesicle budding from the Golgi and endocytosis [10,11].
The rate by which a lipid spontaneously exchanges between
the two bilayer leaﬂets is determined by its structure. Most
membrane lipids, like the phospholipids and glycolipids, have
headgroups of high polarity that reduce the rate of spontane-
ous transbilayer movement and typically yield half-times of
hours for model membranes or plasma membranes like the
erythrocyte membrane [11]. Neutralizing the headgroup charge
by pH or by divalent cations can reduce the translocation half-
time of, for example, free fatty acids [12] or phosphatidic acid
from hours to seconds. Cholesterol with its sole hydroxyl moi-
ety ﬂips in seconds [13,14] and this is also true for the second
messenger lipids ceramide (<1 min) and diacylglycerol (<1 s;
[15,16]). The diﬀerence in translocation half-times for these
latter molecules demonstrates an eﬀect of the lipid backbone
as well. Translocation rates depend on the physical state of
the membrane, and are higher in curved and loosely packed
membranes.3. Monomeric lipid transport
The bulk of the membrane lipids resides in membranes. This
implies by no means that they are unable to leave the mem-
brane. Each type of lipid partitions between the membrane
and the aqueous phase. For most membrane lipids the mono-
meric solubility in water, which inversely correlates with
molecular hydrophobicity and size, is exceedingly low. Still,
some lipids do travel as monomers from the membrane to
other acceptors with half-times that are relevant on biological
time-scales. These half-times are essentially governed by the
oﬀ-rate by which the lipid escapes from the membrane. The
half-time of desorption is 6100 ms for single chain lipids like
fatty acids and lysophospholipids [17], 0.3–3 h for cholesterol,
4–80 h for long-chain phospholipids [18], and even longer for
many sphingolipids [19]. As in the case of transbilayer translo-
cation, the oﬀ-rate is modulated by the curvature and ﬂuidityof the membrane (up to two orders of magnitude faster from
highly curved membranes and 10 times faster from unsatu-
rated PC as compared to SM/cholesterol membranes, W.L.C.
Vaz, personal communication). However, there is one factor
intrinsic to the transport process itself that can dramatically
speed up monomeric transport. Collisional contacts between
the membranes or other lipidic structures can reduce the
half-time of transport by orders of magnitude, probably by
lowering the activation energy needed to overcome the aque-
ous barrier between donor and acceptor surface [20] (Fig. 2).
It is not clear whether such collisions between lipid surfaces oc-
cur inside the cell, but, while ergosterol has been shown to
equilibrate between ER and plasma membrane by non-vesicu-
lar transport with a half-time of 10–15 min [21], and therefore
does not seem to require contact sites, stable contact sites are
held responsible for the eﬃcient transport of PC and PS from
the ER to the mitochondria. An extreme example of facilitated
desorption is the extraction of a lipid from a membrane by li-
pid-binding proteins like lipid transfer proteins. One of these,
the ceramide transfer protein CERT, transports ceramide from
the ER to the sphingomyelin synthase in the late Golgi [22].
CERT may actually be an active component of the contact
sites between ER and Golgi [23]. Lipid transfer proteins of
varying lipid speciﬁcity are present in the cell [7].4. ABC transporters and lipid desorption from cells
The shedding of lipids by mammalian cells into the environ-
ment is a ubiquitous event. Often it represents the monomeric
transport of a speciﬁc type of lipid from the plasma membrane
to an acceptor (surface), and in nearly all cases, disorders
involving defective lipid release from the plasma membrane
have been correlated with mutations in an ABC transporter:
(a) Progressive familial intrahepatic cholestasis (PFIC).
PFIC3: ABCB4 is required for the transport of PC from
the bile canalicular membrane of hepatocytes onto bile
micelles [1,24,25], but not the intestine [26]. PFIC2: The
transfer of bile acids depends on the bile acid transporter
Fig. 3. ABC transporters (red) deposit (arrows) lipids into the surface
monolayer of an extracellular acceptor like HDL, or into internal
membranes inside the lamellar bodies, like the surfactant-containing
storage organelles in lung type II cells or the glucosylceramide-
containing lamellar bodies in keratinocytes.
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erodimer of the ABC half-transporters ABCG5 and G8,
and depends on PC secretion [29].
(b) Sitosterolemia. ABCG5/G8 was also linked to the trans-
port of nutritional (mostly plant) sterols back into the
intestinal lumen [30].
(c) Tangier disease. The reverse transport of cholesterol onto
lipid-poor apoA1 required ABCA1 [31–33], whereas
ABCG1 and G4 are held responsible for transport of cho-
lesterol onto high density lipoprotein (HDL) particles
[34,35].
In other cases, lipids are transferred into the lumen of organ-
elles to be subsequently released by exocytosis or endocytotic
recycling (see Fig. 3). Once again ABC transporter mutations
have been correlated with disease:
(d) Fatal surfactant deﬁciency in newborns. ABCA3 [36] is re-
quired for transporting lipid molecules, mostly saturated
PC, to the lung surfactant membranes ﬁlling the lamellar
bodies in lung epithelial type II cells [37,38]. When re-
leased into the lung the surfactant spreads at the air–water
interface in the alveoli.
(e) Harlequin ichthyosis. Similarly to ABCA3, ABCA12 is
needed for the transport of lipids, mainly glucosylcera-
mide, to the membranes within the lamellar bodies in
keratinocytes [39–41]. These lamellar bodies fuse with
the plasma membrane to release their contents in between
the cells where the glucosylceramide is converted into the
ceramide to form, together with fatty acids and choles-
terol, the extracellular lamellar bilayers between the skin
cells [42].
(f) X-linked adrenoleukodystrophy. This is a neurodegenera-
tive disorder characterized by an accumulation of very
long-chain fatty acids, caused by mutations in ABCD1,
an ABC half-transporter. A subfamily of 4 ABC trans-
porters (ABCD1 to ABCD4) has been related to the trans-
port of these fatty acids or their SCoA esters across the
peroxisomal membrane (see [43,44]).
(g) Stargardt macular dystrophy. An atypical situation exists
for ABCA4. In the photoreceptor discs of the rod outer
segments, ABCA4 seems to transport N-retinylidene-PE
towards the cytosol [45,46], which is the opposite direction
of the other mammalian lipid-transporting ABC trans-
porters. N-retinylidene-PE is released to the cytosol of
the photoreceptors as all-trans-retinal, which is subse-
quently isomerized to 11-cis-retinal to be reutilized by
the photoreceptor by a process that involves transport
across the plasma membrane and extracellular space into
the retinal pigment epithelial cells [47].
A subset of ABC transporters, the multidrug transporters
and especially ABCB1 and ABCC1, exports a variety of
drugs [48,49] from cells. When expressed at high levels, these
transporters are responsible for the chemoresistance pheno-
type. The substrates have in common that they are amphi-
pathic, and they cover a wide range of hydrophobicity.
Although they are generally extruded straight into the extra-
cellular medium, some substrates are extruded eﬃciently only
in the presence of an acceptor for small hydrophobic mole-
cules like serum albumin. The fact that ABCB1 extrudes
platelet activating factor (PAF), a short-chain ether PC
[50,51], while its close relative ABCB4 transports regular
long-chain PCs [1], shows that ABC transporters cover the
whole range of hydrophobicity.Finally, other mechanisms of lipid transport from the exo-
plasmic surface have been identiﬁed. The assembly of secretory
lipoproteins in the lumen of the ER and Golgi cisternae re-
quires the activity of the microsomal transfer protein MTP
[52]. The loading of the immunoglobulin CD1b with a glyco-
lipid in endosomes for presentation as an antigen was found
to be mediated by the ATP-independent sphingolipid activator
saposin C that normally presents glycosphingolipids to hydro-
lytic enzymes in the lysosomes [53].5. Mechanism of ABC transporter-assisted lipid export
The available evidence suggests that most mammalian ABC
transporters pick up their substrate lipid from the cytosolic
surface. First of all, the multidrug transporters pump amphi-
pathic substrates out of the cell, or into reconstituted vesicles,
away from the side of ATP binding [2,48]. In addition, there is
some evidence that natural phospholipids can be transported
to the outside of the plasma membrane by an ABC trans-
porter. The amount of newly synthesized, radiolabeled PC that
could be depleted from the cell surface by the PC transfer pro-
tein or by a bile acid was higher in cells overexpressing ABCB4
[54,55], but a role for vesicular traﬃc was not excluded in those
studies. The exposure of PS on the surface of erythrocytes after
the stimulation by a Ca2+ ionophore was reduced in ABCA1
null mice [56] and in a Scott patient with a missense mutation
in ABCA1 [57]. Finally, the arrival on the erythrocyte surface
of (radiolabeled) PC, newly synthesized on the inner leaﬂet of
the membrane [58], was energy-dependent, sensitive to the
ABC transporter inhibitor glibenclamide, and reduced in
erythrocytes from Abcb1 null mice and from Abcb4 null mice
[59].
In addition, a large body of experiments has shown that ana-
logs of membrane lipids that carry one or two shortened (and
often spin-labeled or ﬂuorescent) fatty acyl chains can be
translocated from the cytosolic surface by the ABC transport-
ers ABCA1, ABCB1, ABCB4 or ABCC1 both in nucleated
cells (e.g. [4,60–63] and erythrocytes [56,59,64,65], and these re-
sults are supported by studies on model membranes containing
puriﬁed ABC transporters [66–68]. Although these reports still
contain some unresolved contradictory results concerning the
substrate speciﬁcity of the transporters, they all conﬁrm the
Fig. 4. Mechanistic models for ABC lipid transporters. (A) In the
ﬂippase model for ABC lipid transporters, the substrate lipid diﬀuses
into the binding site on the cytosolic surface when the transporter is in
the open conformation. ATP-binding dimerizes the nucleotide binding
domains, closes the transporter, and ﬂops the lipid. The lipid may be
expelled during the resetting phase, generating a pressure increase in
the exoplasmic leaﬂet. Alternatively, the lipid exchanges with a
diﬀerent lipid that has a higher aﬃnity for the exoplasmic binding
site. This lipid could then be ﬂipped back, which would maintain the
mass balance across the bilayer. (B) Alternatively, after the substrate
enters the transporter (1), the conformational change may bring the
lipid into an activated state without changing the lipid’s orientation,
hence: ‘‘ﬂopless activation’’ (2,3). If an acceptor is suﬃciently close, for
example if HDL were bound to the ABC transporter (2), the lipid
could diﬀuse onto the acceptor. In the absence of an acceptor (3), the
lipid may block the transporter. On the other hand, the lipid might
relax from its energetically unfavorable position by entering the
exoplasmic bilayer leaﬂet, thereby completing a ‘‘ﬂop’’ movement. The
lipid might change its orientation during or after the activation step.
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main, which is the cytosolic surface. The fact that also regular
hydrophobic membrane lipids like PC [54,55,59], PS [56,57]
and headgroup-labeled PE [67] enter the binding site predicts
that the substrate can freely diﬀuse from the cytosolic bilayer
leaﬂet into the binding site of the transporter.
Essentially, two models have been proposed for how ABC
transporters extrude substrates from the cell. (i) In the ﬂippase
model (Fig. 4A; [69]), the substrate binds in the cytosolic half
of the membrane, is translocated during the ATP-consuming
conformational change of the transporter with a reversal of
its orientation, followed by release into the exoplasmic half
of the bilayer. After this ‘‘ﬂop’’ movement the molecule is free
to partition between the membrane and the extracellular med-
ium. Relatively hydrophilic drugs would quickly partition into
the external environment. However, this model oﬀers no expla-
nation for how lipids reach extracellular acceptors and why
this requires the transporter. (ii) The hydrophobic ‘‘vacuum
cleaner’’ model predicts that the substrate enters a binding site
in the membrane and is subsequently ejected into the extracel-
lular medium [70]. This mechanism thus involves the complete
hydration of the substrate molecule upon the conformational
change of the transporter. This poses a problem in the case
of the regular membrane lipids: the Gibbs’ molar free energyof complete desorption from the membrane into an aqueous
phase for a phospholipid is some 100 kJ/mol [18], whereas
ATP has an energy content of 30 kJ/mol. Assuming that the
ABC transporters consume one or two ATP during their
‘‘power stroke’’, this would generate insuﬃcient energy for
the extrusion of a phospholipid molecule.
A third, ‘‘activation’’, model oﬀers a solution for the incon-
gruencies of the models above (Fig. 4B). Instead of fully mov-
ing the substrate to an aqueous environment, the transporter
would shift the substrate to a location of intermediate hydro-
phobicity on the exoplasmic side of the protein. The substrate
would be in an energetically unfavorable environment and
would therefore be presented in an activated state to an accep-
tor [6,71]. Because the shift would not require a reorientation
of the polar headgroup we term this ‘‘ﬂopless activation’’.
For the multidrug transporters, this model would imply that
the relatively hydrophilic drugs would be immediately released
from this site into the aqueous phase, turning this model into
the hydrophobic vacuum cleaner model. In contrast, in the
case of lipid transporters, the lipids would be stuck to the pro-
tein unless a hydrophobic acceptor surface would allow the li-
pid to leave. Transfer of the lipid from the exoplasmic site on
the transporter to the acceptor would be most eﬃcient if this
acceptor would be bound directly to the transporter. In the ab-
sence of an acceptor, there are various possibilities depending
on how the exoplasmic binding site connects to the exoplasmic
bilayer leaﬂet. One extreme case would be that only the pres-
ence of an acceptor would allow substrate release. This would
lead to the interesting possibility that the ABC transporter can
only start a new reaction cycle in the presence of the acceptor.
In the other extreme case, the exoplasmic binding site in the
ABC transporter would open directly into the exoplasmic leaf-
let of the membrane. In this case the model becomes identical
to the ﬂippase model with the disadvantageous loss of coupling
between the translocation within the protein to the transfer
onto the acceptor. In the intermediate situation, the lipid is
able to move from the transporter into the exoplasmic leaﬂet
of the membrane but with lower probability than moving onto
its cognate acceptor. The possibility that the transfer into the
membrane is regulated by other (membrane) proteins cannot
be excluded. In other words translocation could be uncoupled
from the presence of the acceptor and the transporter would
temporarily turn into a ﬂippase. This suggests the intriguing
possibility that while under normal circumstances the inward
lipid ﬂipping by P-type ATPases would promote vesicle bud-
ding into the cytosol [10,11], under special conditions ABC
transporters could counteract this force and might even drive
budding in the opposite direction. An inhibitory eﬀect of
ABCA1 on endocytosis has been observed [63,72].
Actually, the evidence that ABC transporters can ﬂop lipid
molecules from the cytosolic to the exoplasmic bilayer leaﬂet
is remarkably scarce and indirect. (i) A ﬂoppase activity has
been reported for lipid analogs with one or two shortened
and often polar fatty acyl chains [4,60–62,64–68,73]. Such lipid
analogs have a much reduced activation energy for desorption
[74], and thus their ﬂop is no proof for a ﬂippase model: they
could be extruded into the aqueous phase and partition back
into the (exoplasmic surface of) the membrane. (ii) Some of
the lipid analogs ﬂopped by ABCB1 after reconstitution in
model membranes contained two long-chain fatty acids like
dipalmitoyl- and dioleoyl-PE labeled on the head group with
the ﬂuorescent marker NBD [67]. (iii) Erythrocytes from
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cell surface than normal [56,63], suggesting that ABCA1 may
ﬂop natural PS. (iv) Radiolabeled PC was translocated from
the inner to the outer leaﬂet of mouse erythrocytes by a process
that was ATP-dependent, was inhibited by glibenclamide, and
was reduced in knock-out mice for Abcb1 or Abcb4 [59], sug-
gesting that these molecules ﬂop PC in isolated erythrocytes.6. Mechanistic variations
Similar to the mammalian ABC lipid transporters described
above, the plant Cer5 ABC transporter was required for the
transport of wax molecules (PC26) across the plasma mem-
brane of epithelial cells to the extracellular cuticle [75], and
the bacterial ABC transporter MsbA has been found essential
for the transport of lipid A from the cytosolic surface of the
E. coli inner membrane across that membrane to the outer
membrane [76]. However, many bacterial ABC transporters
transport molecules in the opposite direction into the cytosol
[77]. Invariably, the substrate is supplied to the exoplasmic face
of the transporter by a speciﬁc binding protein. This is exactly
the opposite of the export of lipid molecules by the mammalian
ABC transporters, but involves the same molecular interac-
tions (Fig. 4). Actually, also some mammalian ABC lipid
transporters may transport towards the cytosol. The presence
of intact ABCC7 has been correlated with an increased uptake
of the signaling lipids sphingosine-1-phosphate and lysophos-
phatidic acid [78]. In addition, ABCA4 apparently transports
N-retinylidene-PE towards the cytosolic side of the disc mem-
brane, where it is converted back to all-trans-retinal [47]. It is
unclear how N-retinylidene-PE enters the exoplasmic binding
site. Access of a lipid to an ABC transporter from the exoplas-
mic surface has been shown for the bacterial ABC transporter
LolCDE. It allows a lipid-anchored protein on the exoplasmic
side of the E. coli inner membrane to enter the binding site and
subsequently extrudes the lipoprotein onto an acceptor, the
periplasmic carrier LolA [79]. In mammals, a similar mecha-
nism may be responsible for transferring morphogens like
Hedgehog, which is anchored to the membrane by cholesterol
and palmitate tails, and glycosylphosphatidylinositol-an-
chored proteins from the cell surface to blood lipoproteins,
where they have been found in Drosophila [80].
Although only little evidence is available on the substrate
speciﬁcities of the various ABC transporters due to the lack
of adequate methods, they are clearly diverse. This is well-illus-
trated by the ABCA subfamily. While ABCA1 and A7 are
involved in transport of PC, SM and cholesterol (cholesterol
contested for A7 [81]), ABCA4 seems speciﬁc for N-retinylid-
ene-PE, and the lamellar body transporters ABCA3 and
ABCA12 may be speciﬁc for dipalmitoyl PC (possibly in com-
bination with cholesterol) and glucosylceramide (plus choles-
terol?), respectively (see above). Best characterized is the
selectivity of human ABCB4 for PC: PC is the only phospho-
lipid in human bile [82], while some other mammalian biles
contain SM as well. A selectivity for the translocation of
short-chain PCs over analogs of PE and sphingolipids was then
observed in transfected cells [4] and in an in vitro system [66],
although the latter study missed the fact that ABCB1 is an even
better transporter for these analogs and displays essentially no
selectivity [4]. ABCB1 was reported to also ﬂip a long-chain
ﬂuorescent PE analog [67] and maybe cholesterol (discussedin [83]), and its presence correlated with an enhanced PS expo-
sure on the cell surface [62]. Still, after numerous studies on the
transport activity of ABCB1, one must conclude that it is pri-
marily a multidrug transporter that can also transport the
short-chain PC platelet activating factor [50,51] and that
maybe, under certain conditions, ﬂops natural long-chain lip-
ids. In contrast, ABCB4 is primarily a PC transporter, that also
pumps some drugs (see [84]). The multidrug transporter
ABCC1, like ABCB1, has been reported to transport analogs
of membrane lipids. However, no natural lipid substrates have
been identiﬁed for the ABCC subfamily. The ABCD1-4 half-
transporters homo- or heterodimerize and they probably bind
and transport very long-chain fatty acids or their –SCoA esters
[43,44]. In the ABCG family, the ABCG5/G8 heterodimer
transports cholesterol into the intestinal lumen and into bile
[29,30], while ABCG1 transports cholesterol to HDL [34].
The fact that also this transport to HDL is accompanied by
transport of the choline-phospholipids suggests that choles-
terol may be transported in a complex with PC or SM.7. Future perspectives
The discovery that a number of inherited lipid-linked disor-
ders are due to mutations in ABC transporters has attracted
many research groups to the ﬁeld. Clearly, the action of these
transporters is fundamental to a number of aspects of human
physiology, and an understanding of the basic principles of
their action will greatly improve the diagnosis and treatment
of lipid-related diseases in general. Considering the large num-
ber of ABC lipid transporters, mammals have developed many
diﬀerent applications for what seems to be one basic mecha-
nism: transport of lipids out of the membrane onto some
acceptor. It is a challenge to uncover the mechanistics of the
transport and to understand the structural speciﬁcity of the
transporters. For this it will be necessary to reconstitute
the transporters in model membranes and rebuild their cellular
context from chemically deﬁned components to recreate their
function. In the end, it will be necessary to describe their activ-
ities within the complex lipidomics of the human body [85,86].
This eﬀort will require new methodological approaches and,
above all, a lot of basic research.
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